Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.54 USD | -5.16% | -8.61% | -9.05% |
Jun. 07 | LifeMD Files for $150 Million Mixed Shelf | MT |
Jun. 05 | KeyBanc Initiates LifeMD at Overweight With $12 Price Target, Cites 'Strong Top & Bottom-Line Growth' | MT |
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the past twelve months, EPS forecast has been revised upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- Low profitability weakens the company.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-9.05% | 319M | - | ||
-4.87% | 29.6B | C | ||
+31.35% | 8.65B | C- | ||
+34.03% | 4.42B | B- | ||
-28.91% | 2.69B | C- | ||
-9.91% | 1.6B | - | C+ | |
-21.02% | 1.36B | B | ||
-35.78% | 1.1B | - | ||
+3.28% | 924M | C | ||
-43.36% | 791M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- LFMD Stock
- Ratings LifeMD, Inc.